» Articles » PMID: 35884048

Unique Pulmonary Hypertension in Young Children: A Case Series Study

Overview
Specialty Health Services
Date 2022 Jul 27
PMID 35884048
Authors
Affiliations
Soon will be listed here.
Abstract

Pediatric pulmonary hypertension (PH) has a similar clinical presentation to the adult disease but is associated with several additional disorders and challenges that require a specific approach for their fulminant course. With improved care for premature infants, various forms of pulmonary vascular disease have been found in children that did not previously exist. Pediatric PH can begin in utero, resulting in pulmonary vascularity growth abnormalities that may persist into adulthood. Here, we retrospectively reviewed several unique pediatric PH cases from 2000 to 2020 at Kaohsiung Medical University Hospital, Taiwan, a tertiary teaching hospital. Their comorbidities varied and included surfactant dysfunction, bronchopulmonary dysplasia, premature closure of the ductus arteriosus, high levels of renin and aldosterone, and Swyer-James-Macleod syndrome. Their clinical profiles, radiological characteristics, echocardiography, pulmonary angiogram, and therapeutic regimens were recorded. Further, because the underlying causes of pediatric PH were complex and markedly different according to age, adult PH classification may not be applicable to pediatric PH in all settings. We also classified these cases using different systems, including the Panama classification and the Sixth World Symposium on PH, and compared their advantages and disadvantages.

Citing Articles

: Chamber-specific heart phenotype quantification of zebrafish in high-content screens.

Vedder V, Reinberger T, Haider S, Eichelmann L, Odenthal N, Abdelilah-Seyfried S Front Cell Dev Biol. 2023; 11:1143852.

PMID: 37113769 PMC: 10126419. DOI: 10.3389/fcell.2023.1143852.


Idiopathic Pulmonary Arterial Hypertension in Paediatrics Represents Still a Serious Challenge: A Case Series Study.

Bassareo P, Argiento P, Mcmahon C, Dunne E, Walsh K, Russo M Children (Basel). 2023; 10(3).

PMID: 36980076 PMC: 10047811. DOI: 10.3390/children10030518.

References
1.
Del Cerro M, Abman S, Diaz G, Freudenthal A, Freudenthal F, Harikrishnan S . A consensus approach to the classification of pediatric pulmonary hypertensive vascular disease: Report from the PVRI Pediatric Taskforce, Panama 2011. Pulm Circ. 2011; 1(2):286-298. PMC: 3161725. DOI: 10.4103/2045-8932.83456. View

2.
Chen I, Chen Y, Lin S, Hsu J, Wu J, Dai Z . Usefulness of combination of pulmonary ventilation and perfusion scintigraphy on the diagnosis of children with unilateral hyperlucent lung. Nucl Med Commun. 2011; 32(11):1052-9. DOI: 10.1097/MNM.0b013e32834a6dfd. View

3.
Chen I, Lin J, Liu Y, Chai C, Yeh J, Hsu J . The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction. Int J Med Sci. 2020; 17(16):2594-2602. PMC: 7532484. DOI: 10.7150/ijms.48096. View

4.
Cueto-Robledo G, Jurado-Hernandez M, Camacho-Delgado F, Roldan-Valadez E, Heredia-Arroyo A, Cueto-Romero H . Pulmonary Thromboendarterectomy in Klinefelter Syndrome. Literature Review. Curr Probl Cardiol. 2021; 47(12):101003. DOI: 10.1016/j.cpcardiol.2021.101003. View

5.
Yuce M, Bayram N, Ozer O, Davutoglu V . An unusual cause of pulmonary hypertension: Swyer-James-Macleod syndrome. Int J Cardiol. 2016; 223:212-214. DOI: 10.1016/j.ijcard.2016.08.107. View